| Literature DB >> 30423970 |
Diamantina Marouli1,2, Kostas Stylianou3, Eleftherios Papadakis4, Nikolaos Kroustalakis5, Stavroula Kolyvaki6, Georgios Papadopoulos7, Christos Ioannou8, Alexandra Papaioannou9, Eugene Daphnis10, Dimitris Georgopoulos11, Helen Askitopoulou12.
Abstract
BACKGROUND: Postoperative Acute Kidney Injury (AKI) is a common and serious complication associated with significant morbidity and mortality. While several pre- and intra-operative risk factors for AKI have been recognized in cardiac surgery patients, relatively few data are available regarding the incidence and risk factors for perioperative AKI in other surgical operations. The aim of the present study was to determine the risk factors for perioperative AKI in patients undergoing major abdominal surgery.Entities:
Keywords: albuminuria; chloride; postoperative acute kidney injury
Year: 2018 PMID: 30423970 PMCID: PMC6262448 DOI: 10.3390/jcm7110431
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
AKI * diagnosis based on AKIN ** creatinine criteria. (Patients receiving RRT *** are considered to have met criteria for Stage 3, irrespective of the stage they were at the commencement of RRT).
| AKI Staging | Definition |
|---|---|
| Stage 1 | 1.5-fold increase in sCr or increase of ≥0.3 mg·dL−1 |
| Stage 2 | 2-fold increase in sCr |
| Stage 3 | 3-fold increase in sCr or sCr ≥ 4 mg·dL−1, with acute rise of ≥0.5 mg·dL−1 |
* AKI = acute kidney injury; ** AKIN = Acute Kidney Injury Network; sCr = serum creatinine; *** RRT = renal replacement therapy.
Baseline clinical and demographic characteristics according to AKI status.
| Non-AKI Group ( | AKI Group ( | Odd’s Ratio (95% CI) | ||
|---|---|---|---|---|
|
| ||||
| Mean age, (years ± SD) | 66.9 ± 10 | 68.2 ± 10.4 | 0.699 | 1.01 (0.95–1.08) |
| Male gender, ( | 33 | 8 | 0.67 | 1.02 (0.92–1.13) |
| Mean BMI, kg·m−² | 27.2 ± 4.2 | 27.7 ± 5.6 | 0.721 | 1.03 (0.89–1.19) |
|
| ||||
| ASA II | 27 | 4 | 0.087 | 1.0 |
| ASA III | 20 | 6 | 0.076 | 3.9 (0.73–33.80) |
| ASA IV | 3 | 1 | 0.249 | 4.8 (0.33–70.40) |
|
| ||||
| Hypertension | 31 | 6 | 0.738 | 1.4 (0.20–2.75) |
| CKD | 34 | 9 | 0.481 | 2.1 (0.41–10.95) |
| Stage I | 4 | 2 | 0.226 | 4 (0.42–37.78) |
| Stage II | 25 | 5 | 0.600 | 1.6 (0.28–9.26) |
| Stage III | 5 | 2 | 0.301 | 3.2 (0.35–28.94) |
| CAD | 14 | 4 | 0.717 | 1.5 (0.37–5.81) |
| CHF | 11 | 5 | 0.067 | 3.8 (0.98–14.70) |
| DM | 14 | 5 | 0.137 | 3 (0.76–11.54) |
| COPD | 19 | 6 | 0.174 | 3.1 (0.80–12.09) |
|
| ||||
| Other abdominal Surgery | 35 (89.7%) | 4 (10.3%) | 0.079 | |
| Vascular surgery | 15 (68.2%) | 7 (31.8%) | 0.035 | 4.1 (1.04–16.06) |
Mean (SD): mean and standard deviation (in brackets), n: number of patients OR (95% CI): Odd’s ratio with 95% confidence intervals (in brackets), p-values from Pearson’s chi-square or Fisher’s exact test. Abbreviations: AKI: Acute Kidney Injury; BMI: Body Mass Index; CKD: Chronic Kidney Disease; CAD: Coronary Artery Disease; CHF: Congestive Heart Failure; DM: Diabetes Mellitus; COPD: Chronic Obstructive Pulmonary Disease.
Baseline laboratory values according to AKI status (expressed as mean ± SD, except UACR which is expressed in numbers of patients).
| Non-AKI Group ( | AKI Group ( | Odd’s Ratio (95% CI) | ||
|---|---|---|---|---|
| Serum Creatinine, mg·dL−1 | 0.87 (±0.23) | 1.02 (±0.21) | 0.063 | 12.6 (0.80–198.7) |
| Serum Cystatin C, mg·L−1 | 0.76 (±0.19) | 0.82 (±0.28) | 0.319 | 5.20 (0.21–126.7) |
| eGFR, mL·min−1 1.73 m−2 | 83.92 (±15.15) | 75.27 (±15.97) | 0.095 | 0.97 (0.93–1.01) |
| Urine Albumin, mg·L−1 | 24.1 (±50.7) | 325 (±729.9) | 0.042 | 1.01 (1.00–1.01) |
| Urine Creatinine, g·L−1 | 1.1 (±0.6) | 1.2 (±0.7) | 0.344 | 1.66 (0.58–4.66) |
| UACR > 30 mg·gr−1, ( | 9 (18.0) | 6 (54.5) | 0.011 | 5.47 (1.36–21.92) |
| FeNa, % | 0.8 (±0.7) | 0.8 (±0.8) | 0.919 | 1.05 (0.40–2.75) |
| FeUrea, % | 41.4 (±12.7) | 37.2 (±10.5) | 0.303 | 0.97 (0.92–1.03) |
Mean (SD): mean and standard deviation (in brackets), n: number of patients. OR (95% CI): Odd’s ratio with 95% confidence intervals (in brackets), p-values from Pearson’s chi-square or Fisher’s exact test. Abbreviations: AKI: Acute Kidney Injury; eGFR: estimated Glomerular Filtration Rate; UACR: Urine Albumin to Creatinine Ratio; FeNa: Fractional Excretion of Sodium; FeUrea: Fractional Excretion of Urea.
Intraoperative variables according to AKI status (expressed as mean ± SD, except Vasopressors which are expressed in numbers of patients).
| Non-AKI Group ( | AKI Group ( | Odd’s Ratio (95% CI) | ||
|---|---|---|---|---|
|
| ||||
| Urine output (mL·kg−1·hr−1) | 2.1 (±2.0) | 1.1 (±0.8) | 0.151 | 0.37 (0.13–1.1) |
| Mean Arterial Pressure (mmHg) | 78.7 (±6.9) | 79.6 (±10.5) | 0.734 | 1.01 (0.93–1.10) |
| Vasopressor administration, ( | 32 (64.0) | 8 (72.7) | 0.581 | 1.67 (0.86–2.65) |
| Blood loss (mL) | 479 (±508.5) | 1345.5 (±1336.7) | 0.002 | 1.06 (1.02–1.1) |
|
| ||||
| Total crystalloids (mL) | 2441 (±1195) | 3018 (±1497) | 0.171 | 1.00 (1.00–1.00) |
| Total colloids (mL) | 865 (±354) | 1046 (±611) | 0.191 | 1.00 (1.00–1.00) |
| RBC transfusion (units) | 1.1 (±1.4) | 2.3 (±2.4) | 0.042 | 1.49 (1.03–2.01) |
| FFP transfusion (units) | 1.2 (±1.4) | 2.6 (±2.1) | 0.006 | 1.69 (1.11–2.56) |
| PLT transfusion (units) | 0.04 (±0.28) | 0.4 (±1.2) | 0.088 | 2.04 (0.73–5.71) |
| Chloride load (mEq) | 458.6 (±179.8) | 583.9 (±191.5) | 0.043 | 1.03 (1.01–1.05) |
Mean (SD): mean and standard deviation (in brackets), n: number of patients; OR (95%CI): Odd’s ratio with 95% confidence intervals (in brackets); p-values from Pearson’s chi-square or Fisher’s exact test. AKI: Acute Kidney Injury; RBC: Red Blood Cells; FFP: Fresh Frozen Plasma; PLT: Platelets.
Figure 1Estimated glomerular filtration rate (eGFR) at predefined time-points. Open boxes represent non-AKI patients, shaded boxes AKI patients. Boxes and whiskers show interquartile ranges and total observed ranges, respectively. eGFR: estimated Glomerular Filtration Rate; Pre-op: preoperatively; RR: recovery room; POD1: postoperative day 1; POD3: postoperative day 3; POD5: postoperative day 5; POD7: postoperative day 7.
Figure 2Serum creatinine measurements at predefined time-points. Open boxes represent non-AKI patients, shaded boxes AKI patients. Boxes and whiskers show interquartile ranges and total observed ranges, respectively. Pre-op: preoperatively; RR: recovery room; POD1: postoperative day 1; POD3: postoperative day 3; POD5: postoperative day 5; POD7: postoperative day 7.
Figure 3Serum cystatin C measurements at predefined time-points. Open boxes represent non-AKI patients, shaded boxes AKI patients. Boxes and whiskers show interquartile ranges and total observed ranges, respectively. Pre-op: preoperatively; RR: recovery room; POD1: postoperative day 1; POD3: postoperative day 3; POD5: postoperative day 5; POD7: postoperative day 7.